Details
ISBN/EAN: 978-3-659-56287-7
Einband: kartoniertes Buch
Weitere Details
Auflage:
1. Auflage 2014
1. Auflage 2014
Erschienen am:
09.08.2014
09.08.2014
Sprache:
English
English
Umfang:
80 S.
80 S.
Format (T/L/B):
0.6 x 22 x 15 cm
0.6 x 22 x 15 cm
Hersteller:
OmniScriptum SRL
info@omniscriptum.com
Str. Armeneasca 28/1, office 1
MD 2012 Chisinau
OmniScriptum SRL
info@omniscriptum.com
Str. Armeneasca 28/1, office 1
MD 2012 Chisinau
Weitere Details
arrow_forward_ios
Logistic Model In Reliability Of Tb Drugs
Efficacy Of Tb Drugs In Recovery Of Tuberculosis Patients
Beschreibung
Tuberculosis cases are rising in the upper east region and the curing rate of tuberculosis in the region is low, the second lowest curing rates in worldwide. This research was conducted to assess the growth in the healing process (survivability growth) and drug intervention (reliability of the TB drug) in recovery of tuberculosis patients.The study revealed that the drug for the treatment of tuberculosis is reliable since there was a positive drug intervention in the treatment of the disease and this was due to the continuous TB drug developments through making new TB antibiotics drugs ( badaquiline and delamanid ), the combination of antibiotics (multiple drugs administration) and the act of research. Also there was growth in the healing process (survivability growth).The average healing time for TB patients to be cured from TB is about 25.69 weeks (180) days. From the analyses, the outcome of treatment had a success rate of 74% and that other factors that affect the recovery and treatment outcome of TB patients such as age, HIV infection, gender, alcoholism, and intravenous drug practice. The study recommends that TB patients must always complete the full course of TB treatment
Über Eric Boahen
Mr.Eric Boahen is a lecturer at the University For Development Studies (UDS), Tamale in Ghana at the Faculty of Mathematical Sciences, Department of Statistics.He obtained his Master of Science Degree in Biometry from UDS. He is currently a PHD candidate in Biometry. His study areas are Survival analysis, missing values, and clinical trials.